Join
Live feed
·
PRReleasevia Quantisnow
Citius Pharmaceuticals Inc. logo
TenX Keane Acquisition logo

Citius Pharmaceuticals Announces TenX Keane Shareholder Approval of Merger with Citius Oncology, Inc.

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CTXR (Citius Pharmaceuticals Inc.), TENK (TenX Keane Acquisition) and more on Quantisnow.